Couverture de Solutions with Henry Blodget

Solutions with Henry Blodget

Solutions with Henry Blodget

De : Vox Media Podcast Network
Écouter gratuitement

À propos de ce contenu audio

We hear enough about our problems. Let’s solve them. Every Monday, journalist, analyst and entrepreneur Henry Blodget interviews leading thinkers across business, tech, politics and beyond about their big ideas for how to build a better future. Part of the Vox Media Podcast Network. Economie
Épisodes
  • Are Psychedelics on the Verge of Going Mainstream?
    May 11 2026
    President Trump surprised many people a few weeks ago when he signed an executive order accelerating research into psychedelics. Compounds like psilocybin, LSD, MDMA, ketamine, and others have developed large and enthusiastic followings in the past decade, and some seem quite promising in the treatment of depression, PTSD, addiction and other conditions. Unusually, they are also one of the very few issues that have support across the political spectrum. This week, we discuss why this is a turning point for psychedelics and what might come next with Anne Philippi, a former journalist at Vogue, Vanity Fair, and GQ who now runs The New Health Club, a media organization dedicated to psychedelics. Learn more about your ad choices. Visit podcastchoices.com/adchoices
    Afficher plus Afficher moins
    40 min
  • Why AI Will Never Be Conscious, According to a Consciousness Expert
    May 4 2026
    Anil Seth is concerned about the “mythology of conscious AI” – the growing argument that LLMs and other AI systems might one day achieve consciousness. Seth is a Professor of Cognitive and Computational Neuroscience at the University of Sussex and a leading expert on consciousness. He’s skeptical that AI will ever achieve true consciousness, and argues there’s danger in perceiving these technical systems as feeling beings. Today, we discuss that danger, and what science even defines as "consciousness." Learn more about your ad choices. Visit podcastchoices.com/adchoices
    Afficher plus Afficher moins
    1 h et 7 min
  • An Extraordinary Gene Editing Treatment Could Mark a Turning Point in Medicine
    Apr 27 2026
    In the summer of 2024, a baby named KJ was born with a rare disease with a 50% mortality rate. Six months later, he became the first patient to receive personalized gene editing therapy. He is now healthy and thriving. Dr. Jeff Coller, who directs the RNA Innovation Center at Johns Hopkins University, says KJ’s treatment could be the most important medical story of the decade. Today, Dr. Coller explains the ground-breaking science behind KJ’s treatment, and what it will take to bring it mainstream. Learn more about your ad choices. Visit podcastchoices.com/adchoices
    Afficher plus Afficher moins
    47 min
adbl_web_anon_alc_button_suppression_c
Aucun commentaire pour le moment